Jack Nathan Medical Corp. (JNHMF)
| Previous close | 0.1061 |
| Open | 0.1001 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.1001 - 0.1001 |
| 52-week range | 0.0740 - 0.4500 |
| Volume | |
| Avg. volume | 4,674 |
| Market cap | 9.141M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0770 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Jack Nathan Health to Open More Medical Clinics Within Walmart Locations Across Canada
TORONTO, May 09, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") and Wal-Mart Canada Corp. ("Walmart Canada") announced today that they have signed a new Credit Facility and new licensed locations to drive rapid expansion of new additional Jack Nathan Medical Clinics across Canada.
- GlobeNewswire
Proposed Disposition of Common Shares of Jack Nathan Medical Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR OVER UNITED STATES NEWSWIRE SERVICES GEORGETOWN, Ontario, Feb. 22, 2022 (GLOBE NEWSWIRE) -- This press release is being disseminated as required by National Instrument 62–103 - The Early Warning System and Related Take Over Bids and Insider Reporting Issues in connection with the filing of an early warning report by George Barakat in respect of the disposition of common shares in the capital of Jack Nathan Medical Corp. ("JNMC") (TSXV:JNH.V). George
- Business Wire
Jack Nathan Health Announces Its Q3 Fiscal 2022 Financial Results
TORONTO, December 31, 2021--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited consolidated interim financial results for the third quarter of fiscal 2022, ended October 31, 2021. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
